» Authors » Birgit Geoerger

Birgit Geoerger

Explore the profile of Birgit Geoerger including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 164
Citations 4546
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Mascarenhas L, Dubois S, Albert C, Bielack S, Orbach D, Federman N, et al.
J Clin Oncol . 2025 Mar; :JCO2500353. PMID: 40030088
No abstract available.
2.
Mascarenhas L, Dubois S, Albert C, Bielack S, Orbach D, Federman N, et al.
J Clin Oncol . 2025 Feb; 43(8):1046. PMID: 39951654
No abstract available.
3.
Mascarenhas L, Dubois S, Albert C, Bielack S, Orbach D, Federman N, et al.
J Clin Oncol . 2025 Jan; :JCO2400848. PMID: 39869835
Larotrectinib is a highly selective tropomyosin receptor kinase (TRK) inhibitor with efficacy in children with TRK fusion tumors. We evaluated patient outcomes after elective discontinuation of larotrectinib in the absence...
4.
Lamoureux A, Fisher M, Lemelle L, Pfaff E, Amir-Yazdani P, Kramm C, et al.
Clin Cancer Res . 2024 Dec; 31(3):561-572. PMID: 39625867
Purpose: Tropomyosin receptor kinase (TRK) fusions are detected in less than 2% of central nervous system tumors. There are limited data on the clinical course of affected patients. Experimental Design:...
5.
Berlanga P, Aerts I, Corradini N, Ndounga-Diakou L, Entz-Werle N, Ducassou S, et al.
Pediatr Blood Cancer . 2024 Nov; 72(2):e31449. PMID: 39558828
SACHA-France (NCT04477681) is a prospective real-world study that collects clinical safety and efficacy data of novel anticancer therapies prescribed off-label or on compassionate use to patients <25 years. From March...
6.
Geoerger B, Bautista F, Andre N, Berlanga P, Gatz S, Marshall L, et al.
Eur J Cancer . 2024 Jul; 208:114201. PMID: 39018630
Precision cancer medicine brought the promise of improving outcomes for patients with cancer. High-throughput molecular profiling of tumors at treatment failure aims to direct a patient to a treatment matched...
7.
Rich J, Bennaroch M, Notel L, Patalakh P, Alberola J, Issa F, et al.
EMBO Mol Med . 2024 Jul; 16(8):1840-1885. PMID: 39009887
We have recently identified the uncharacterized ZNF555 protein as a component of a productive complex involved in the morbid function of the 4qA locus in facioscapulohumeral dystrophy. Subsequently named DiPRO1...
8.
Glaviano A, Wander S, Baird R, Yap K, Lam H, Toi M, et al.
Drug Resist Updat . 2024 Jun; 76:101103. PMID: 38943828
Cell cycle dysregulation is a hallmark of cancer that promotes eccessive cell division. Cyclin-dependent kinase 4 (CDK4) and cyclin-dependent kinase 6 (CDK6) are key molecules in the G1-to-S phase cell...
9.
Thuilliez C, Moquin-Beaudry G, Khneisser P, Marques Da Costa M, Karkar S, Boudhouche H, et al.
Bioinform Adv . 2024 Jun; 4(1):vbae081. PMID: 38915885
Motivation: Spatial transcriptomics enables the analysis of cell crosstalk in healthy and diseased organs by capturing the transcriptomic profiles of millions of cells within their spatial contexts. However, spatial transcriptomics...
10.
Bautista F, Verdu-Amoros J, Geoerger B, Rubio-San-Simon A, Paoletti X, Zwaan C, et al.
J Clin Oncol . 2024 May; 42(21):2516-2526. PMID: 38743911
Purpose: The aim of the Innovative Therapies for Children with Cancer (ITCC) consortium is to improve access to novel therapies for children and adolescents with cancer. The evolution of the...